Clinical trial
Urge Incontinence Bladder Overactivity Study
NCT00475696 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00475696 |
|---|---|
| Title | Urge Incontinence Bladder Overactivity Study |
| Official title | Long-Term Monitoring of Safety in Subjects Treated With Duloxetine for Bladder Overactivity |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Urinary Incontinence |
| Intervention type | Drug |
| Interventions | Duloxetine |
| Enrollment | 300 |
| Start date | Nov 1, 2002 |
| Completion | Mar 1, 2005 |
| First posted | May 21, 2007 |
| Last update posted | May 21, 2007 |
| Countries | Australia, Canada, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: